Skip to main content
. Author manuscript; available in PMC: 2018 Jan 12.
Published in final edited form as: Hypertension. 2017 May 15;70(1):192–200. doi: 10.1161/HYPERTENSIONAHA.116.08832

Figure 1. Change in plasma and urinary ET-1.

Figure 1

Change from baseline ± SEM in plasma ET-1 (A), urinary ET-1 excretion (B), fractional excretion of ET-1 (FeET-1) (C) and urine ET-1/creat following treatment with placebo (blue line) and big ET-1 (red line). **p <0.01, ***p <0.001 and ****p <0.0001 for placebo vs. big ET-1 (ANOVA plus Bonferroni correction for significance at specific time points).